Åsa Petersén has been elected member of the executive committee for the European Huntington Disease Network (EHDN). The EHDN is a nonprofit research network committed to advancing research, facilitating the conduct of clinical trials, and improving clinical care in HD. Through the EHDN a platform has been created such that basic scientists, clinicians, patients and families can collaborate on academic and industry studies to fulfil its mission. The EHDN is supported by and collaborates closely with CHDI Foundation, Inc.
Find out more about EHDN on the organization’s website: